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The use of functional performance tests and simple anthropomorphic measures to screen 
for comorbidity in primary care 
 
Abstract 
Background: Many older adults are unaware that they have comorbid diseases. Increased 
adiposity and reduced muscle mass are identified as key contributors to many chronic diseases 
in older adults. Understanding the role they play in the development of comorbidities in older 
populations is of prime importance.  
Objectives: To identify the optimal body shape associated with three common functional 
performance tests and to determine which anthropometric and functional performance test best 
explains comorbidity in a sample of older adults in Hong Kong. 
Methods: A total of 432 older adults participated in this cross-sectional study. Researchers 
assessed their body height, body mass index, waist circumference, waist-to-hip ratio, handgrip 
strength (kg), functional reach (cm), and results in the Timed Up and Go (TUG) test (seconds). 
The Charlson Comorbidity Index was used to assess comorbidity.  
Results: Allometric modelling indicated that the optimal body shape associated with all 
functional performance tests would have required the participants to be taller and leaner. The 
only variable that predicted comorbidity was the TUG test. The inclusion of body size/shape 
variables did not improve the prediction model. 
Conclusion: Performance in the TUG test alone was found to be capable of identifying 
participants at risk of developing comorbidities. The TUG test has potential as a screening tool 
for the early detection of chronic diseases in older adults.  
Implications for Practice: Many older people are unaware of their own co-existing illnesses 
when they consult physicians for a medical condition. TUG can be a quick and useful screening 
measure to alert nurses in primary care to the need to proceed with more detailed assessments. 
It is an especially useful screening measure in settings with high patient volumes and fiscal 
constraints. TUG is low-cost and easy to learn, and is therefore also relevant for nurses and 
health workers in low-resource, low-income countries.  
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Implications for practice 
 
What does this research add to existing knowledge in gerontology? 
• Many older adults, particularly those with lower levels of literacy and those living in 
developing or underdeveloped countries, are unaware of their own comorbid 
conditions.  
• This cross-sectional study found that performance in the TUG test alone can identify 
participants at risk of developing comorbidities. Further studies will be useful to 
verify this finding.  
What are the implications of this new knowledge for nursing care with older people? 
• The TUG test costs little and is easy to administer. It should be promoted in health 
assessments of older people, particularly in settings with high patient volumes and/or 
fiscal constraints, or in low-resource, low-income countries.  
• The test is non-invasive in nature and therefore likely to be acceptable to older adults 
as an assessment measure. 
How could the findings be used to influence research, education, policy, or practice? 
• Many older adults, especially those with low levels of literacy, are often unaware of 
their comorbidities even when they visit their doctor for a medical consultation. Using 
a simple TUG test will help to alert clinicians to the possibility of comorbid 
conditions in their clients or patients. A finding that is outside of the normal range can 
prompt further evaluation by nurses and other health care providers, and can therefore 
facilitate early referrals to physicians for timely diagnosis and treatment of any 
comorbid conditions. 
• Under the supervision of nurses and allied health professionals, community health 
workers in settings with manpower shortages and fiscal constraints – as well as those 
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in low-resource, low-income countries – can learn how to use the TUG test at a 
minimal cost.  
• It is suggested that replication studies be conducted in other populations to further 





On chronic illness and comorbidity 
Globally, the top four major chronic diseases are cardiovascular disease, cancer, 
chronic respiratory disease, and diabetes; these are responsible for close to 80% of deaths from 
non-communicable diseases (World Health Organization, 2018). Eighty to 85% of older adults 
have at least one chronic condition (National Council on Aging, 2018; National Institute of 
Aging, 2017). Comorbidity, defined as the simultaneous presence of two or more diseases in 
an individual (Newman, 2012), has been observed in two-thirds of older adults worldwide 
(Marengoni et al., 2011). Comorbidities may be associated with each other through 
pathogenetic mechanisms (Grumbach, 2003) that contribute to patient complexity.   
Chronic comorbidities contribute to the burden and cost of many different medical 
conditions that have been reported (Cortaredona & Ventelou, 2016). Both comorbidity and 
multi-morbidity have been found to be associated with mortality (Ferrer, Formiga, Sanz, 
Almeda, & Padrós, 2017; Fraccaro et al., 2016), disability, and poor functional status (Garin et 
al., 2014; Ryan, Wallace, O'Hara, & Smith, 2015), poor quality of life (Wang, Palmer, Cocker, 
& Sanderson, 2017), and higher health service utilization (van Oostrom et al., 2014).  
Unfortunately, patient awareness of chronic diseases is reportedly low (Cavanaugh et 
al., 2008). Moreover, even if most patients are aware of their primary medical diagnosis, a large 
number may not be aware that they have comorbidities (Bansode & Nagarajan, 2017). Those 
who are affected by dementia (Fox et al., 2014; Scrutton & Brancati, 2016) or are less educated 
(Hoffmann et al., 2018) are compromised in their ability to provide timely reports to their 
formal caregivers about their comorbid health problems.  
Increased adiposity and reduced muscle mass as contributors to chronic diseases  
Increased adiposity and reduced muscle mass with ageing have been identified as key 
contributors to many chronic diseases in older adults (Chang, Beason, Hunleth, & Colditz, 
2012). There is substantial evidence that obesity is an important contributor not only to 
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cardiovascular disease and diabetes, but also to cancer, arthritis, liver and kidney diseases, as 
well as to other adverse health outcomes (Pi-Sunyer, 2009). These complications are associated 
with obesity in older populations (Amarya, Singh, & Sabharwal, 2014), yet it is not known 
which anthropometric measure best predicts health risks in obese older people (Mathus-
Vliegen et al., 2012).   
Muscle mass has also been found to be a strong predictor of many chronic diseases 
suffered by older people, such as diabetes (Kim et al., 2014) and cardiovascular disease (Afilalo 
et al., 2014). However, measuring muscle mass usually involves expensive imaging procedures 
(e.g., dual X-ray absorptiometry) (Tosato et al., 2017). Consequently, simple anthropometric 
and functional performance measures are more commonly used as markers to identify chronic 
diseases in primary healthcare settings. 
Anthropometric and functional measures as predictors of comorbidity 
Systematic reviews have suggested that the majority of studies overwhelmingly rely on 
body mass index (BMI) as a measure of adiposity (Chang et al., 2012). Notwithstanding the 
criticisms of BMI as a measure, the process of ageing results in greater central adiposity 
(MacInnis et al., 2006). Therefore, measures of central adiposity, waist circumference (WC), 
and waist-to-hip ratio (WHR) may be better predictors of the risk of comorbidities in older 
adults (Chang et al., 2012). 
Nevill et al. (2017) examined the question of what would be the most appropriate 
anthropometric index associated with cardiovascular disease risk in adults aged 20-69 years 
( Nevill, Duncan, Lahart, & Sandercock, 2017). Using an allometric approach, they compared 
BMI, WC, WHR, waist-to-height ratio, and A Body Shape Index (ABSI) results as predictors 
of cardiovascular risk. ABSI is a recently developed measure of adiposity (Geraci et al., 2019). 
Nevill et al. found that the ratio of waist to height (0.5) was a better predictor of cardiovascular 
disease risk than the other predictors.  In the context of an older adult population and given the 
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limitations of prior studies using anthropometric indices of risk, it is important to determine 
which anthropometric indicator of obesity best predicts comorbidity in primary care settings, 
at a relatively low cost, in order to prevent chronic diseases.  
Functional assessment tools are frequently used as prognostic tools by researchers and 
clinicians (Carey, Walter, Lindquist, & Covinsky, 2004). Poor functional status is associated 
with adverse health outcomes (Shah, Leonard, & Thakar, 2018), including hospitalizations and 
emergency room visits (O’Hoski et al., 2019), higher healthcare costs (Chuang et al., 2003), 
nursing home admission (Gaugler, Duval, Anderson, & Kane, 2007) and death (Carey et al., 
2004). More work has been done on prognostic evaluations using functional measures of 
mortality than using measures of morbidity. For example, Formiga et al. (2016) studied the 
predictive value of functional impairment, chronic conditions, and laboratory biomarkers of 
ageing to predict mortality (Formiga et al., 2016). Wu and team (2016) examined functional 
status, health-related quality of life, and survival in cardiac patients (Wu, Lennie, Frazier, & 
Moser, 2016).  
Slow gait is associated with sarcopenic obesity as well as with many subclinical 
conditions (Waters, Hale, Grant, Herbison, & Goulding, 2010). Jacob et al. (20I7) reported that 
a subgroup of their older participants with mobility limitations from existing musculoskeletal 
conditions as well as other comorbidities had the worst functional impairment among all of 
their participants (Jacob et al., 2017). Gait speed has been regarded as an objective measure of 
physical function in older adults for predicting morbidity and mortality (Albert, Bear-Lehman, 
& Anderson, 2015; Lyons et al., 2016). It has been studied as a predictor of falls (Verghese, 
Holtzer, Lipton, & Wang, 2009) and poor long-term outcomes such as disabilities (Flint et al., 
2018), nursing home placement (Lyons et al., 2016), and survival (Studenski et al., 2011; Wu 
et al., 2016). Other functional measures, such as the Timed Up and Go (TUG) test, provide 
more information than just measures of gait speed in the risk of falls and other outcomes (Laddu 
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et al., 2018). From their longitudinal study, Bergland et al. (2017) found that the TUG score is 
significantly associated with mortality (Bergland, Jargensen, Emaus, & Strand, 2017). Pieper, 
Bowling and Fillenbaum (2019) reported that the level and trajectory of comorbidity correlated 
with the functional measures in their longitudinal sample (Pieper, Bowling, & Fillenbaum, 
2019).  
This background illustrates that it is important to understand the role of increased 
adiposity, reduced muscle mass, and functional performance in relation to chronic conditions 
and comorbidities in an older adult population. Performance-based measures may be 
particularly useful in clinical settings serving community populations, because they are easy to 
perform and require only a few minutes to complete (Viccaro, Perera, & Studenski, 2011). 
Nurses play a pivotal role in primary health care (Pan American Health Organization, 2018), 
and such simple prognostic indicators can help them to carry out this role in screening and 
health promotion. 
The aim of this study was to: 1) examine which anthropometric index best explains and 
predicts functional performance in a sample of older adults from Hong Kong; 2) examine which 
anthropometric index best explains and predicts comorbidity; and 3) examine which functional 
performance test, in combination with anthropometric characteristics, best explains and 




This paper is part of a longitudinal study on frailty conducted by the project team, 
although the data presented here is cross-sectional in design. The aim of the main study on 
frailty was to examine factors associated with the development of frailty over time.   
Convenience sampling was employed. Non-governmental organizations (NGOs) throughout 
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the territory of Hong Kong were approached. These NGOs offer a range of services for older 
people, including operating senior centers and providing day care, home care, and long-term 
residential care. The NGOs that agreed to support this study disseminated information about it 
to their service clientele, sought their approval (or that of their proxies) to take part in the study, 
and obtained their phone numbers so that the research personnel could contact them. The 
participants were then approached and provided with a detailed explanation of the study. 
Written informed consent was obtained from each participant before they could take part in the 
study.   
 
Participants 
The criteria for eligibility to participate in this study were: 1) being aged 60 or older; 
and 2) ability to communicate in Cantonese, the major dialect in Hong Kong. Written consent 
was obtained from the participants or from their proxies if their Abbreviated Mental Test (AMT) 
score was lower than 7 (which indicates possible cognitive impairment). A more inclusive 
approach was adopted in setting up the recruitment criteria so as to identify a diverse sample 
of community participants. This study was approved by the Human Subjects Ethics Sub-
Committee of The Hong Kong Polytechnic University (HSEARS20130609001). 
 
Data collection 
The participants were assessed in terms of their demographic data (gender, age, years 
of education, economic status, religion, fall history, and smoking and drinking habits), physical 
measures (including hip and waist circumferences, body weight, and BMI), and functional 
status (handgrip strength, TUG test, and functional reach). There is as yet no clear scientific 
definition of body shape, but various studies have demonstrated that waist-to-hip ratio (WHR) 
(calculated by waist circumference divided by hip circumference) and body mass index (BMI) 
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(calculated by body weight in kilograms divided by the square of body height in metres) can 
be used to quantify body shape. The classifications of WHR and BMI are already well 
established. Two new anthropometric indices of adiposity – the A Body Shape Index (ABSI) 
and the Body Roundness Index (BRI) – have been developed in recent years as possible 
alternatives to BMI and waist circumference (Geraci et al., 2019). The calculation of ABSI 
involves waist circumference, BMI, and body weight. The data were collected by trained 
undergraduate nursing students through face-to-face interviews and assessments of the 
participants. If needed, supplementary information such as confirmed medical diagnoses were 
provided by the proxies or formal caregivers. The students were trained up to the point at which 
they were able to achieve no less than 90% agreement with the two key expert assessors in the 




Three measures of functional performance – handgrip strength (HG, measured in kg), 
the timed-up-and-go (TUG, measured in seconds) test, and functional reach (FR, measured in 
cm) – were adopted in the present study. These measures were used because they represent key, 
widely used tests for determining different aspects of the functional performance of older 
populations. 
Grip strength is a recommended clinical measure of general muscle strength (Ong et al., 
2017; Roberts et al., 2011). Handgrip strength (dominant hand) was assessed using the Jamar 
handheld dynamometer (hydraulic), following guidelines reported by Mathiowetz (Mathiowetz, 
1990). Three trials were undertaken, with the mean score of the last two trials being taken for 
subsequent analysis. A study of older populations in Singapore showed that the handgrip 
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strength of the Chinese subgroup aged between 65 to 85 and above ranged from 12.79 to 18.93 
kg (Ong et al., 2017).  
The TUG test is regarded as a combined measure of muscular strength, limb movement 
speed, and agility (Rikli & Jones, 1999). The TUG was administered following previously 
described procedures (Podsiadlo & Richardson, 1991). The TUG test involved taking note of 
the number of seconds required by an individual to get up from a seated position, walk 3 metres, 
turn, and return to a seated position. Two trials were undertaken, with the results of the second 
attempt being used for a subsequent analysis. Taking a shorter time to complete TUG indicates 
a better ability to balance. The cut-off level for TUG is 13.5 seconds or longer (Shumway-
Cook, Brauer, & Woollacott, 2000). Its validity and reliability were confirmed in a study 
conducted in Hong Kong (Ng & Hui-Chan, 2005). 
The functional reach test is considered a measure of dynamic balance (P. W. Duncan, 
Weiner, Chandler, & Studenski, 1990) . FR correlates with physical frailty (Weiner, Duncan, 
Chandler, & Studenski, 1992) and is used for detecting balance impairment and changes in 
balance performance over time (P. W. Duncan et al., 1990). It measures the distance an 
individual can reach in the forward direction from a comfortable standing posture without 
experiencing a loss of balance. The administration of the test followed previously described 
procedures (P. W. Duncan et al., 1990). The participants were asked to flex the shoulder of 
their dominant arm, with the elbow joint fully extended, and then to reach as far as possible 
without taking a step, while ensuring that their heels remain in contact with the ground. A metre 
measure was mounted horizontally on the wall at the same height as the acromion. Reach 
distance was measured as the displacement of the most distal part of the hand from the initial 
to the end position (P. W. Duncan et al., 1990) . Three trials were undertaken. The first attempt 
was employed as a practice trial to familiarize the participant with the procedure. The mean 
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value of the two subsequent trials was used for analysis. An inability to reach more than 15 
centimetres indicates a high fall risk and frailty (Weiner et al., 1992).   
Comorbidity 
The Charlson Comorbidity Index (CCI) was employed in the current study to measure 
comorbidity (ME Charlson, Pompei, Ales, & MacKenzie, 1987) . It consists of 19 comorbid 
conditions, such as cardiovascular disease, dementia, diabetes, and chronic pulmonary diseases. 
The age-adjusted CCI was calculated using a previously reported method (Charlson, 
Szatrowski, Peterson, & Gold, 1994) , in which comorbid conditions were weighted and scored, 
with additional points added for age. A score of 0-1 was considered low and a CCI of ≥ 2 was 
regarded as high (Ofori-Asenso et al., 2018). CCI scores of 0, 1-2, 3-4, and ≥5 represent 
comorbidity levels of none, low, medium, and high, respectively. In the medical literature, CCI 
is the most extensively studied as well as the most widely used index for studying comorbidity 
(Maringe, Fowler, Rachet, & Luque-Fernandez, 2017). CCI has also been validated in an older 
population in Hong Kong (Chan, Luk, Chu, & Chan, 2014). 
 
Statistical Analysis 
To identify the characteristics of body size and shape most closely associated with the 
three physical performance (PP) variables (handgrip strength, TUG, functional reach test) and 
the CCI in this older population, as well as any differences in the population (sex, age group), 
we adopted the following multiplicative model (Eq. 1) with allometric body size components. 
This model is similar to one that has been used to model the physical performance variables of 
Greek and Peruvian children (Bustamante Valdivia, Maia, & Nevill, 2015; Nevill, Tsiotra, 





 Y = a · massk1 · heightk2 waist k3· Ɛ  (Eq. 1) 
 
where k1, k2, and k3 are the mass, height, and waist exponents and ‘a’ is the intercept parameter 
that is allowed to vary between groups (sex, age group, etc.). This model has the advantage of 
having proportional body-size components that will identify the most appropriate height-to-
weight-to-waist ratio associated with different measures of physical performance (Y). Note that 
‘ε’, the multiplicative error ratio, where the assumption is that the error will increase in 
proportion to the physical performance variables (PP) or CCI dependent variables Y; see, for 
example, the heteroscedasticity present in Fig. 5. (Heteroscedasticity refers to data with 
unequal variability scattered across a second, predictor variable)  
The model (Eq. 1) can be linearized with a log transformation. A linear regression 
analysis on log(Y) can then be used to estimate the unknown parameters of the log transformed 
model (i.e., the transformed model 2 is now additive, which conforms with the assumptions 
associated with ordinary least squares):  
 
 log(PP) = log(a) + k1·log(height)+k2·log(mass)+ k3·log(waist) + log(Ɛ). (Eq. 2) 
 
Further categorical or group differences within the population (e.g., sex and age group) 
can be explored by allowing the constant intercept parameter ‘log(a)’ in Eq. 2 to vary for each 
group (by introducing them as fixed factors within an ANCOVA) using log(height), log(mass), 
and log(waist) as covariates. Having fitted the saturated model (all available variables including 
sex, age group, and the age-by-sex interaction plus the three body size dimensions), an 
appropriate ‘parsimonious’ model can be obtained using ‘backward elimination’ (Draper and 
Smith, 1981), in which at each step the least important (non-significant) body size variable is 
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dropped from the current model. Statistical Packages for the Social Science (SPSS) version 20 
was used in all analyses, and the level of significance was set at P < 0.05. 
The influence of body size, composition, and shape in physical performance tests in 
older adults is a matter of continuing debate (Tomas, Galan-Mercant, Carnero, & Fernandes, 
2018). To investigate which body size/shape characteristics and type of physical performance 
(HG, TUG, and FR) would best be able to explain and predict the comorbidity in the sample, 
the multiplicative allometric model (Eq. 1) was expanded to incorporate the physical 
performance variables (HG, TUG, and FR) as follows: 
 CCI = a · massk1 · heightk2 waist k3· HGk4 · TUGk5 FR k6· Ɛ  (Eq. 1a) 
where k4, k5, and k6 are the additional HG, TUG, and FR exponents. As before, ‘a’ is the 
intercept parameter that is allowed to vary between groups (sex, age group, etc.). The model 
(Eq. 1a) can be linearized with a log transformation and linear regression analysis or ANCOVA 
can then be used to estimate the unknown parameters of the log transformed model, i.e., by 
allowing sex and age group as fixed factors in the ANCOVA and using log(height), log(mass), 
log(waist), log(HG), log(TUG), and log(FR), as covariates.  
The allometric approach is a suitable model to use to answer our research questions, 
given its sound theoretical basis and versatile statistical methodology (Nevill 1997; Nevill et 
al. 2004). This technique can be used in comparisons between groups that differ in size, 




A total of 432 older adults (mean age = 78.0 ± 9.0 years) participated in this study. The 
majority lived in the community (71.8%), were female (71.5%), retired (78.5%), non-smokers 
(86.6%), and non-drinkers (92.6%). Almost half had an educational attainment of secondary 
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school or lower (56.7%). The mean number of chronic diseases that they had been diagnosed 
with was 3.1 ± 1.9. The number of people (373 out of the total of 432 = 87%) had two or fewer 
comorbidities, as measured using the CCI. The three most common comorbidities found in this 
sample of participants were diabetes (25.2%), cardiovascular disease (17.4%), and connective 
tissue disease (8.1%). Details of the demographic characteristics and health conditions of the 
participants are shown in Table 1. 
 ---Table 1 about here--- 
 
Results to explain Aim 1 
Handgrip strength 
To examine which anthropometric index best explained functional performance in the 
sample, we compared the results of the handgrip strength test, the TUG test, and the functional 
reach test. Concerning the handgrip strength test, the multiplicative model relating handgrip 
strength (kg) (Eq. 3) to the body size components was found to be:  
 
Handgrip strength (kg) = a · mass1.08 · height1.72 · waist-1.35,   (Eq. 3) 
 
with the mass, height, and waist exponents being k1 = 1.084 (SEE = 0.210), k2 = 1.717 (SEE = 
0.654), and k3 = -1.345 (SE = 0.252), respectively. Note that the mass and height exponents 
were both positive, but the waist exponent was negative. The adjusted coefficient of 
determination, adjusted R2, was 40.2%. The constant ‘a’ varied by sex and age group, but no 
interaction was identified between age group and sex (p > 0.05), as seen in Fig. 1 below.  
 ---Figure 1 about here--- 
Timed Up and Go (TUG) Test  
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The multiplicative model relating the TUG(s) (Eq. 4) to the body size components was 
found to be:  
 
Timed get up and go test(s) = a· height -0.914 · waist 0.779,   (Eq. 4) 
 
with the height and waist exponents being k2 = -0.914 (SEE = 0.451) and k3 = 0.779 (SE = 
0.174), respectively. Note that, for this test, the waist exponent was positive but the height 
exponent was negative. The adjusted coefficient of determination, adjusted R2, was 29.1%. The 
constant ‘a’ varied by age group alone, a trend that increased with each age group and that was 
common to both males and females, as seen in Fig. 2 below.  
 ---Figure 2 about here--- 
Functional Reach 
The multiplicative model relating the functional reach test (cm) (Eq. 5) to the body size 
components was found to be:  
 
Functional reach test (cm) = a· mass0.894 · waist-1.315,    (Eq. 5) 
 
with the mass and waist exponents being k1 = 0.894 (SEE = 0.261) and k3 = -1.315 (SE = 
0.334), respectively. Note that, for this test, the mass exponent was positive but the waist 
exponent was negative. The adjusted coefficient of determination, adjusted R2, was 15.5%. The 
constant ‘a’ varied by age group alone, a trend that increased with each age group and that was 
common to both male and females, as seen in Fig. 3 below.  
 ---Figure 3 about here--- 
In addressing the first research question, handgrip was found to have the greatest 




Results to explain Aim 2 
Comorbidity 
The second research question attempts to examine which anthropometric index best 
explained comorbidity. Here, the multiplicative model (Eq. 1) was also adopted to identify the 
optimal body size and shape characteristics associated with the CCI and the three body size 
components. The parsimonious solution (Eq. 6) was found to be as follows:  
 
CCI = a· mass-0.295 · waist0.564,   (Eq. 6) 
 
with the mass and waist exponents being k1 = -0.295 (SEE = 0.117) and k3 = 0.564 (SE = 
0.149), respectively. Note that, for this test, the mass exponent was negative but the waist 
exponent was positive. The adjusted coefficient of determination, adjusted R2, was 55.3%. The 
constant ‘a’ varied by age group and sex (main effects, no interaction), a trend that increased 
with each age group and that was greater for males than for females, as seen in Fig. 4 below. 
Table 2 shows the TUG scores in seconds by age group and sex. 
 ---Figure 4 about here--- 
 
Results to explain Aim 3 
To investigate which body size/shape characteristics AND physical performance test 
(HG, TUG, and FR) were best able to explain the comorbidity in the sample, the multiplicative 
allometric model (Eq. 1a) identified the following parsimonious solution (Eq. 7) requiring just 
one physical performance variable (TUG) covariate to predict CCI:  
 




with the TUG exponent being k = 0.184 (SEE = 0.032). The adjusted coefficient of 
determination, adjusted R2, was 58.2%. The association between CCI and TUG can clearly be 
seen in Figure 5. Note that the heteroscedastic errors observed in Fig. 5 fully support the need 
to adopt the log-linear allometric modelling approach as described in the methods section, i.e., 
the ‘shot-gun’ effect, where CCI clearly increases with greater TUG times that will naturally 
be controlled by taking logs. The constant ‘a’ varied by age group alone, a trend that increased 
with each age group and that was common to both males and females, as seen in Fig. 6 below.  
 ---Figure 5 and 6 about here--- 
 
Discussion 
This study determined which anthropometric index best explained/predicted functional 
performance and comorbidity in a sample of older adults from Hong Kong, and then examined 
which functional performance test best explained/predicted comorbidity in the same sample. 
Although there are a number of studies (Garin et al., 2014; Ryan et al., 2015) that have 
examined comorbidity and functional performance in older age, no study to date has used the 
allometric approach (e.g., body weight and waist circumference) documented in the current 
study. As such, the results of the current study extend the understanding of how body shape 
relates to functionality and comorbidity in older adults.  
Allometric scaling, as used here, enables scientists and clinicians to account for known 
differences in body size when examining health-related variables, making it possible to better 
quantify the impact of age on these variables. The changes in body composition and, 
subsequently, body shape due to ageing are well established (Montero-Fernandez & Serra-
Rexach, 2013). However, researchers continue to favor BMI as the main anthropometric 
measure of adiposity in older adults, despite known changes in central adiposity as age 
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increases (Chang et al., 2012). Although other anthropometric measures have been used in the 
context of comorbidity, the resulting data are equivocal (Chang et al., 2012). The present study 
provides additional clarity with regard to the body shape that best explains functional 
performance and comorbidity in this sample of older adults in Hong Kong.  
In addressing the first research question, our results suggest that there are different body 
shape contributors (height, body mass, and waist circumference) to each of the functional tests 
that were examined. Handgrip strength was best explained by a height times mass divided by 
waist circumference ratio. Clearly, being taller and heavier but with as little waist adiposity as 
possible with benefit handgrip strength performances. Similarly, TUG performance was best 
explained by a height-to-waist circumference ratio. Here, the faster performances (interpreted 
as a speed of m.s-1, not measured simply in terms of time, as reported in Eq. 4) would be 
achieved by taller but more slender individuals. In order to provide a physiological 
interpretation of the coefficients reported in Equations 3-5, Astrand and Rodahl (1986,  Table 
9.1, p406) have provided an insight into dimensions in physics and physiology that relate to 
the three performance tests in the current study. In their classification L is a linear dimension 
of body size, L2 cross sectional area and L3 is a volumetric dimension such as body mass.  In 
equation 3, for handgrip strength, the sum of the exponents equates to L3 in terms of Astrand 
and Rodahl’s classification (i.e., three dimensions). This reflects the energy requirement to 
perform the movement. While it may have been anticipated that cross sectional area (L2) would 
have been predominant in explaining handgrip strength, the current study suggests that for this 
population, performance relies on three dimensions reflecting the overall energy requirements 
needed to perform the action. Equation 4 predicted TUG is proportional to approximately 
height divided by waist. Velocity, as is the case in TUG performance relates to a dimensionless 
function which agrees with the observations in the current study. The coefficients for functional 
reach (equation 6) predominantly reflect a linear dimension with small contribution from cross 
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sectional area, according to Astrand and Rodahl’s (1986) classification. Such a finding is 
logical with functional reach being a product of body length (height), with contribution from 
the body’s cross- sectional area (waist circumference). 
When data relating to comorbidity were examined to address the second research 
question, CCI scores were best explained or predicted by a positive waist circumference 
exponent and a negative body mass exponent, i.e., waist-to-mass ratio, where increased waist 
circumference per body mass was associated with greater comorbidity (see Eq. 6). The results 
of the present study suggest that comorbidity scores would increase in instances where there is 
a lower body mass but increased waist circumference. This would be indicative of increased 
central adiposity and/or a decrease in total muscle mass and be congruent with prior research 
(Montero-Fernandez & Serra-Rexach, 2013). 
The third aim of the present study was to examine the utility of the three functional tests 
(HG, TUG, & FR) assessed here to explain comorbidity. All three tests are commonly used in 
the literature because they relate to independent living and are considered key functional 
indicators for older adults (Unhjem, van den Hoven, Nygard, Hoff, & Wang, 2019). When we 
examined CCI scores along with height, mass, waist circumference, and the scores for the three 
functional performance tests, a parsimonious model was revealed where only TUG was 
required to predict comorbidity. This finding has a number of important implications. The TUG 
reflects a combination of measures of muscular strength, gait speed, and agility, and therefore 
provides a holistic measure of functional motor performance for older adults. In order to 
perform well on the TUG test, an individual needs to have the capacity to generate high muscle 
force as quickly as possible, alongside dynamic balance – qualities that have been identified as 
essential for good functioning during older adulthood (Unhjem et al., 2019). Individuals with 
a more favorable body shape, i.e., a smaller waist circumference and body mass within the 
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normal range, will also perform better on this test. Furthermore, scores on the TUG test could 
potentially be used to pre-screen for comorbidity in community settings.  
Health professionals need to be mindful of co-existing conditions when seeing patients 
who seek medical attention for a particular condition. Even though people may consult a doctor 
for a primary condition, they may not be aware of other co-existing medical problems. The 
issue of multi-morbidity is a growing global health concern (Academy of Medical Sciences, 
2018). The prevalence of multi-morbidities among older people in low-resource, low-income 
countries has been found to be high, for instance, reaching a level of 53.8% in rural Bangladesh 
(Khanam et al., 2011). Unfortunately, as previously mentioned, awareness of chronic diseases 
among patients is low despite more than 80% of older people have more than one medical 
condition. TUG is therefore potentially useful for promoting public and community health 
because it is a low-cost and time-efficient test and, based on the current study, has clinical 
relevance for healthcare for ageing populations.  
The mean TUG score of our sample was 16.3 (SD 11.9) seconds. In Asia, the mean 
TUG value was 13.3 seconds among community-dwelling elderly aged 65 and older in Taiwan 
(Lin et al., 2004). Older people with a TUG score reflecting poorer functional mobility (long 
duration in seconds) are more likely to be at risk of a higher level of comorbidities. A trend of 
age-related declines in mean TUG test scores has been observed among both male and female 
subjects (Steffen, Hacker, & Mollinger, 2002), and was also noted in our study.  
Nurses are regarded as well positioned to advance primary care (Flaherty & Bartels, 
2019). Early signs of a poor TUG performance should prompt nurses and other healthcare 
providers such as community health workers under their supervision to make further 




There are, of course, limitations to the current study. The cross-sectional sample 
prevents a determination of causality, i.e., does an increase in waist circumference result in 
poorer functional performance or does impaired functionality result in reduced mobility, 
leading to an increase in waist circumference? The sample size was not large and the sample 
was recruited through convenience sampling, thus the generalizability of the findings needs 
further testing.  
 
Conclusion 
In summary, the current study suggests that a person’s performance in the TUG test can 
identify that person’s risk of reporting comorbidities. No other anthropometric or body 
size/shape variables have been found to improve the prediction model. The elements that are 
required to perform well in the TUG test, such as the ability of an individual to make dynamic 
movements of his/her body mass as quickly as possible, may better differentiate comorbidity 
than static functional tests. Thus, for an older population, the TUG test has the potential to act 
as a screening tool for the identification and prevention of chronic diseases, and is particularly 
relevant for clinical settings with high patient volumes, as well as for low-resource, low-income 
countries. Further investigations of the predictive ability of the TUG test may give primary 






ABSI: A Body Shape Index; AMT: Abbreviated Mental Test; ANCOVA: Analysis of 
Covariance; BMI: Body Mass Index; BRI: Body Roundness Index; CCI: Charlson 
Comorbidity Index; NGOs: Non-Governmental Organizations; PP: Physical Performance; SE: 
Standard Error; SEE: Standard Error of Estimation; SPSS: Statistical Packages for the Social 
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FIGURE CAPTIONS 
Figure 1. The mean (± SE) log-transformed handgrip strength (kg) by age group and sex, 
adjusted for differences in log(mass), log(height), and log(waist).  
Figure 2 The mean (±SE) result in the log-transformed Timed Up and Go test (sec) by age 
group, adjusted for differences in log(height) and log(waist). 
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Figure 3 The mean (±SE) result of the log-transformed functional reach test (cm) by age group, 
adjusted for differences in log(mass) and log(waist).  
Figure 4 The mean (±SE) result of the log-transformed Charlson Comorbidity Index (CCI) by 
age group and sex (main effects, no interaction), having controlled for log(mass) and log(waist). 
Figure 5 The Charlson Comorbidity Index (CCI) versus the Timed Up and Go test (TUG) 
results (sec) 
Figure 6 The mean (±SE) result in the log-transformed Charlson Comorbidity Index (CCI) by 
age group, adjusted for differences in log(TUG) test results 
 
TABLE CAPTIONS 
Table 1 Details of the demographic characteristics and health conditions of the participants 
(N=432). 
Table 2 TUG scores in seconds by age group and sex. 
 
